{"id":4856,"date":"2026-03-30T15:05:23","date_gmt":"2026-03-30T15:05:23","guid":{"rendered":"https:\/\/vantagebiotrials.com\/?p=4856"},"modified":"2026-03-30T15:05:23","modified_gmt":"2026-03-30T15:05:23","slug":"bionj-biopartnering-may-12-2026","status":"publish","type":"post","link":"https:\/\/vantagebiotrials.com\/fr\/bionj-biopartnering-may-12-2026\/","title":{"rendered":"BioNJ BioPartnering | May 12, 2026"},"content":{"rendered":"<h2 data-section-id=\"1bhxasn\" data-start=\"455\" data-end=\"507\"><span role=\"text\"><strong data-start=\"458\" data-end=\"507\">Vantage BioTrials at BioNJ BioPartnering 2026<\/strong><\/span><\/h2>\n<p data-start=\"509\" data-end=\"740\"><span class=\"hover:entity-accent entity-underline inline cursor-pointer align-baseline\"><span class=\"whitespace-normal\">Vantage BioTrials<\/span><\/span> will attend the <span class=\"hover:entity-accent entity-underline inline cursor-pointer align-baseline\"><span class=\"whitespace-normal\">BioNJ<\/span><\/span> BioPartnering Conference on May 12, 2026 in New Jersey, as part of the <span class=\"hover:entity-accent entity-underline inline cursor-pointer align-baseline\"><span class=\"whitespace-normal\">BioQu\u00e9bec<\/span><\/span> delegation.<\/p>\n<p data-start=\"742\" data-end=\"956\">This event brings together biotechnology companies, pharmaceutical organizations, investors, and service providers. It creates a valuable setting for collaboration and discussion across the life sciences ecosystem.<\/p>\n<p data-start=\"958\" data-end=\"1187\">As clinical programs become more complex, early alignment between sponsors and CRO partners is increasingly important. As a result, strong operational planning and clear communication are essential for successful trial execution.<\/p>\n<hr data-start=\"1189\" data-end=\"1192\" \/>\n<h2 data-section-id=\"t4q4f6\" data-start=\"1194\" data-end=\"1231\"><span role=\"text\"><strong data-start=\"1197\" data-end=\"1231\">Representing Vantage BioTrials<\/strong><\/span><\/h2>\n<p data-start=\"1233\" data-end=\"1335\"><span class=\"hover:entity-accent entity-underline inline cursor-pointer align-baseline\"><span class=\"whitespace-normal\">Vatche Bartekian<\/span><\/span>, President of Vantage BioTrials, will attend the conference.<\/p>\n<p data-start=\"1337\" data-end=\"1562\">As a member of <a title=\"BioQu\u00e9bec\" href=\"https:\/\/bioquebec.com\/en\/home\/\" target=\"_blank\" rel=\"noopener\">BioQu\u00e9bec<\/a>, Vantage BioTrials is pleased to join the Qu\u00e9bec delegation once again. This participation highlights the strength of Qu\u00e9bec\u2019s life sciences ecosystem and its growing role in global clinical research.<\/p>\n<hr data-start=\"1564\" data-end=\"1567\" \/>\n<h2 data-section-id=\"46tx2h\" data-start=\"1569\" data-end=\"1624\"><span role=\"text\"><strong data-start=\"1572\" data-end=\"1624\">Full-Service Clinical Trial Management Expertise<\/strong><\/span><\/h2>\n<p data-start=\"1626\" data-end=\"1763\">Vantage BioTrials has supported sponsors for nearly two decades. Our model focuses on structured, full-service clinical trial management.<\/p>\n<p data-start=\"1765\" data-end=\"1790\">Our capabilities include:<\/p>\n<ul data-start=\"1792\" data-end=\"2006\">\n<li data-section-id=\"xrgio5\" data-start=\"1792\" data-end=\"1837\">Clinical project management and oversight<\/li>\n<li data-section-id=\"1aeh20r\" data-start=\"1838\" data-end=\"1863\">Risk-based monitoring<\/li>\n<li data-section-id=\"2sgsf4\" data-start=\"1864\" data-end=\"1894\">Quality management systems<\/li>\n<li data-section-id=\"1cnj600\" data-start=\"1895\" data-end=\"1935\">Study start-up and site coordination<\/li>\n<li data-section-id=\"d9axfn\" data-start=\"1936\" data-end=\"1956\">Vendor oversight<\/li>\n<li data-section-id=\"1nhbbb4\" data-start=\"1957\" data-end=\"2006\">Management of complex and late-phase programs<\/li>\n<\/ul>\n<p data-start=\"2008\" data-end=\"2275\">In addition, our approach is grounded in Quality by Design (QbD) principles. It also includes proactive risk mitigation from the earliest stages of development. Therefore, potential challenges are identified early and managed effectively throughout the study.<\/p>\n<p data-start=\"2277\" data-end=\"2372\">\ud83d\udc49 Learn more about our <a title=\"Therapeutic Expertise\" href=\"https:\/\/vantagebiotrials.com\/therapeutic-area\/\" target=\"_blank\" rel=\"noopener\">therapeutic expertise<\/a>.<\/p>\n<hr data-start=\"2374\" data-end=\"2377\" \/>\n<h2 data-section-id=\"74p8s0\" data-start=\"2379\" data-end=\"2441\"><span role=\"text\"><strong data-start=\"2382\" data-end=\"2441\">Supporting Clinical Development in a Changing Landscape<\/strong><\/span><\/h2>\n<p data-start=\"2443\" data-end=\"2597\">Today, clinical development is evolving rapidly. Consequently, sponsors are looking for CRO partners who can provide both execution and strategic support.<\/p>\n<p data-start=\"2599\" data-end=\"2658\">At BioNJ, we look forward to discussing key topics such as:<\/p>\n<ul data-start=\"2660\" data-end=\"2837\">\n<li data-section-id=\"m6pz5r\" data-start=\"2660\" data-end=\"2708\">Managing complexity across clinical programs<\/li>\n<li data-section-id=\"anwa0z\" data-start=\"2709\" data-end=\"2742\">Supporting lean sponsor teams<\/li>\n<li data-section-id=\"1ybcnrc\" data-start=\"2743\" data-end=\"2790\">Maintaining data quality and patient safety<\/li>\n<li data-section-id=\"xl7iou\" data-start=\"2791\" data-end=\"2837\">Applying structured, risk-based approaches<\/li>\n<\/ul>\n<p data-start=\"2839\" data-end=\"2971\">These discussions are critical. They help ensure that promising therapies move forward efficiently while maintaining high standards.<\/p>\n<hr data-start=\"2973\" data-end=\"2976\" \/>\n<h2 data-section-id=\"psed4y\" data-start=\"2978\" data-end=\"3010\"><span role=\"text\"><strong data-start=\"2981\" data-end=\"3010\">About BioNJ BioPartnering<\/strong><\/span><\/h2>\n<p data-start=\"3012\" data-end=\"3193\">The BioNJ BioPartnering Conference is a leading life sciences event in the United States. It brings together innovators, investors, and partners to support collaboration and growth.<\/p>\n<p data-start=\"3195\" data-end=\"3234\">\ud83d\udc49 Learn more: <a class=\"decorated-link cursor-pointer\" title=\"BioNJ\" href=\"https:\/\/www.bionj.org\/\" target=\"_blank\" rel=\"noopener\" data-start=\"3212\" data-end=\"3234\">https:\/\/www.bionj.org\/<\/a><\/p>\n<hr data-start=\"3236\" data-end=\"3239\" \/>\n<h2 data-section-id=\"14gtz2a\" data-start=\"3241\" data-end=\"3278\"><span role=\"text\"><strong data-start=\"3244\" data-end=\"3278\">Connect with Vantage BioTrials<\/strong><\/span><\/h2>\n<p data-start=\"3280\" data-end=\"3372\">If you plan to attend BioNJ BioPartnering 2026, we would welcome the opportunity to connect.<\/p>\n<p data-start=\"3374\" data-end=\"3540\">We would be pleased to discuss how structured clinical trial management, proactive risk mitigation, and collaborative execution can support your development programs.<\/p>","protected":false},"excerpt":{"rendered":"<p>Vantage BioTrials at BioNJ BioPartnering 2026 Vantage BioTrials will attend the BioNJ BioPartnering Conference on May 12, 2026 in New Jersey, as part of the BioQu\u00e9bec delegation. This event brings together biotechnology companies, pharmaceutical organizations, investors, and service providers. It creates a valuable setting for collaboration and discussion across the life sciences ecosystem. As clinical programs become more complex, early alignment between sponsors and CRO partners is increasingly important. As a result, strong operational planning and clear communication are essential for successful trial execution. Representing Vantage BioTrials Vatche Bartekian, President of Vantage BioTrials, will attend the conference. As a member of BioQu\u00e9bec, Vantage BioTrials is pleased to join the Qu\u00e9bec delegation once again. This participation highlights the strength of Qu\u00e9bec\u2019s life sciences ecosystem and its growing role in global clinical research. Full-Service Clinical Trial Management Expertise Vantage BioTrials has supported sponsors for nearly two decades. Our model focuses on structured, full-service clinical trial management. Our capabilities include: Clinical project management and oversight Risk-based monitoring Quality management systems Study start-up and site coordination Vendor oversight Management of complex and late-phase programs In addition, our approach is grounded in Quality by Design (QbD) principles. It also includes proactive risk mitigation from the earliest stages of development. Therefore, potential challenges are identified early and managed effectively throughout the study. \ud83d\udc49 Learn more about our therapeutic expertise. Supporting Clinical Development in a Changing Landscape Today, clinical development is evolving rapidly. Consequently, sponsors are looking for CRO partners who can provide both execution and strategic support. At BioNJ, we look forward to discussing key topics such as: Managing complexity across clinical programs Supporting lean sponsor teams Maintaining data quality and patient safety Applying structured, risk-based approaches These discussions are critical. They help ensure that promising therapies move forward efficiently while maintaining high standards. About BioNJ BioPartnering The BioNJ BioPartnering Conference is a leading life sciences event in the United States. It brings together innovators, investors, and partners to support collaboration and growth. \ud83d\udc49 Learn more: https:\/\/www.bionj.org\/ Connect with Vantage BioTrials If you plan to attend BioNJ BioPartnering 2026, we would welcome the opportunity to connect. We would be pleased to discuss how structured clinical trial management, proactive risk mitigation, and collaborative execution can support your development programs.<\/p>","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[19],"tags":[],"class_list":["post-4856","post","type-post","status-publish","format-standard","hentry","category-events","cms-no-post-thumbnail"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/vantagebiotrials.com\/fr\/wp-json\/wp\/v2\/posts\/4856","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vantagebiotrials.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vantagebiotrials.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/vantagebiotrials.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/vantagebiotrials.com\/fr\/wp-json\/wp\/v2\/comments?post=4856"}],"version-history":[{"count":3,"href":"https:\/\/vantagebiotrials.com\/fr\/wp-json\/wp\/v2\/posts\/4856\/revisions"}],"predecessor-version":[{"id":4859,"href":"https:\/\/vantagebiotrials.com\/fr\/wp-json\/wp\/v2\/posts\/4856\/revisions\/4859"}],"wp:attachment":[{"href":"https:\/\/vantagebiotrials.com\/fr\/wp-json\/wp\/v2\/media?parent=4856"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vantagebiotrials.com\/fr\/wp-json\/wp\/v2\/categories?post=4856"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vantagebiotrials.com\/fr\/wp-json\/wp\/v2\/tags?post=4856"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}